| scholarly article | Q13442814 |
| P50 | author | Raoul Christian Sutter, MD, PD, FMH | Q46732389 |
| P2093 | author name string | Stephan Marsch | |
| Peter W Kaplan | |||
| Stephan Rüegg | |||
| Peter Fuhr | |||
| P2860 | cites work | Propofol versus thiopental sodium for the treatment of refractory status epilepticus | Q24201548 |
| A modified poisson regression approach to prospective studies with binary data | Q29615575 | ||
| Refractory status epilepticus | Q30436209 | ||
| A randomized trial for the treatment of refractory status epilepticus. | Q34024128 | ||
| EFNS guideline on the management of status epilepticus in adults | Q34091095 | ||
| Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review | Q34570571 | ||
| A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group | Q34752382 | ||
| Hemodynamic changes during thiopental anesthesia in humans: cardiac output, stroke volume, total peripheral resistance, and intrathoracic blood volume | Q35281506 | ||
| The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists | Q35475202 | ||
| Acute phase proteins and white blood cell levels for prediction of infectious complications in status epilepticus | Q36072997 | ||
| Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation | Q36226433 | ||
| Status epilepticus and brain damage: pathology and pathophysiology. | Q36355892 | ||
| Age-dependent consequences of status epilepticus: animal models | Q36850249 | ||
| Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons | Q37049594 | ||
| Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus | Q37157181 | ||
| Guidelines for the evaluation and management of status epilepticus | Q38004984 | ||
| Status epilepticus and the use of continuous EEG monitoring in the intensive care unit. | Q38027357 | ||
| Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study. | Q38027579 | ||
| Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study. | Q38028609 | ||
| When can odds ratios mislead? | Q41742782 | ||
| Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience | Q43297043 | ||
| Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus | Q43747004 | ||
| Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome | Q43866023 | ||
| Refractory status epilepticus: frequency, risk factors, and impact on outcome | Q43885520 | ||
| Refractory status epilepticus: a prospective observational study | Q44832149 | ||
| Independent external validation of the status epilepticus severity score. | Q45935087 | ||
| Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy | Q46390833 | ||
| It's time to revise the definition of status epilepticus | Q46722956 | ||
| Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study | Q46732247 | ||
| Refractory status epilepticus: effect of treatment aggressiveness on prognosis | Q46802749 | ||
| Status epilepticus: an independent outcome predictor after cerebral anoxia | Q48102323 | ||
| Hypersensitivity of the anesthesia-induced comatose brain. | Q48560237 | ||
| Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. | Q51329756 | ||
| Guidelines for Epidemiologic Studies on Epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy | Q53980075 | ||
| Nonconvulsive status epilepticus | Q79214885 | ||
| Etiology of a short-term mortality in the group of 750 patients with 920 episodes of status epilepticus within a period of 10 years (1988-1997) | Q82664862 | ||
| A clinical score for prognosis of status epilepticus in adults | Q83978243 | ||
| Predictors of outcome in refractory status epilepticus | Q85895978 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | status epilepticus | Q980709 |
| P304 | page(s) | 656-664 | |
| P577 | publication date | 2013-12-06 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study | |
| P478 | volume | 82 |
| Q37201609 | (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study |
| Q47116651 | A Study of Super Refractory Status Epilepticus from India |
| Q39208359 | Acute Resective Surgery for the Treatment of Refractory Status Epilepticus. |
| Q47731492 | An update on the recognition and treatment of non-convulsive status epilepticus in the intensive care unit |
| Q39250965 | Anesthetic-Related Neurotoxicity and Neuroimaging in Children: A Call for Conversation |
| Q47359567 | Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort Study. |
| Q40150721 | Association of seizure duration and outcome in refractory status epilepticus |
| Q38394968 | Can anesthetic treatment worsen outcome in status epilepticus? |
| Q96306599 | Clinical outcomes and treatments effectiveness in status epilepticus resolved by antiepileptic drugs: A five-year observational study |
| Q38513028 | Combination drug therapy for the treatment of status epilepticus |
| Q86093114 | Comments on Maganti R et al. Nonconvulsive status epilepticus. Epilepsy & behavior 2008;12:572-586 |
| Q26746873 | Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus |
| Q39278813 | Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany |
| Q38691719 | Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany |
| Q64927994 | Dexamethasone as Abortive Treatment for Refractory Seizures or Status Epilepticus in the Inpatient Setting. |
| Q38670344 | Distinguishing in-hospital and out-of-hospital status epilepticus: clinical implications from a 10-year cohort study |
| Q92916622 | Duration of therapeutic coma and outcome of refractory status epilepticus |
| Q47409388 | EEG Characteristics of Successful Burst Suppression for Refractory Status Epilepticus |
| Q43650360 | Early predictors of refractory status epilepticus: an international two-center study. |
| Q28821401 | Effects of clobazam for treatment of refractory status epilepticus |
| Q92667097 | Electrographic seizure burden and outcomes following pediatric status epilepticus |
| Q36909082 | Evaluation of a clinical tool for early etiology identification in status epilepticus. |
| Q53608555 | Extended EEG and non-convulsive status epilepticus: Benefit over routine EEG? |
| Q42178351 | Finding the Lesser of Two Evils: Treating Refractory Status Epilepticus |
| Q33753851 | First-in-man allopregnanolone use in super-refractory status epilepticus. |
| Q35590568 | Functional outcome of prolonged refractory status epilepticus. |
| Q92329759 | Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society |
| Q38815369 | Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management |
| Q39112997 | Hidden in plain sight: Non-convulsive status epilepticus-Recognition and management. |
| Q52581629 | Ictal Interictal Continuum Patterns. |
| Q36620651 | Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. |
| Q59336095 | Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus |
| Q39797473 | Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study |
| Q30278847 | Intravenous anesthesia in treatment of nonconvulsive status epilepticus: Characteristics and outcomes |
| Q30399934 | Lacosamide in status epilepticus: Systematic review of current evidence. |
| Q91441991 | Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy |
| Q38630760 | New understanding of nonconvulsive status epilepticus in adults: treatments and challenges |
| Q36272258 | New-onset refractory status epilepticus: Etiology, clinical features, and outcome |
| Q88185388 | Newer Antiepileptic Drugs for Status Epilepticus in Adults: What's the Evidence? |
| Q46153907 | Non-convulsive status epilepticus and non-convulsive seizures in neurological ICU patients |
| Q41596667 | Nonconvulsive Seizures and Periodic Discharges: No Longer Such Innocent Bystanders |
| Q92315228 | Nonconvulsive seizures and nonconvulsive status epilepticus in the neuro ICU should or should not be treated aggressively: A debate |
| Q38803784 | Nonconvulsive status epilepticus in adults - insights into the invisible. |
| Q41494364 | Outcomes of patients with altered level of consciousness and abnormal electroencephalogram: A retrospective cohort study. |
| Q48170445 | Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults. |
| Q26796689 | Pharmacotherapy for Status Epilepticus |
| Q47979387 | Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus |
| Q30278891 | Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal. |
| Q36183506 | Predictive value of the Status Epilepticus Severity Score (STESS) and its components for long-term survival |
| Q91023529 | Predictors of mortality at one year after generalized convulsive status epilepticus |
| Q41754928 | Preliminary results of the global audit of treatment of refractory status epilepticus |
| Q36139745 | Procalcitonin and mortality in status epilepticus: an observational cohort study |
| Q30276170 | Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital |
| Q90555717 | Refractory and Super-refractory Status Epilepticus |
| Q40799423 | Refractory and super-refractory status epilepticus in adults: a 9-year cohort study |
| Q30807706 | Refractory and super-refractory status epilepticus--an update. |
| Q30703796 | Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome |
| Q42368392 | Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case-Control Analysis from Germany |
| Q40236390 | Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country |
| Q30277237 | Status Epilepticus |
| Q89220870 | Status epilepticus bei Erwachsenen |
| Q38439932 | Status epilepticus in adults |
| Q64101985 | The Neuroprotective Effect of Astaxanthin on Pilocarpine-Induced Status Epilepticus in Rats |
| Q39354540 | Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study |
| Q30396733 | Topiramate in the Treatment of Generalized Convulsive Status Epilepticus in Adults: A Systematic Review with Individual Patient Data Analysis |
| Q41318447 | Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus |
| Q38968069 | Treating epileptic emergencies - pharmacological advances |
| Q89160827 | Treatment of Refractory and Super-refractory Status Epilepticus |
| Q54943200 | Updates in Refractory Status Epilepticus. |
| Q58091037 | Variability in pharmacologically-induced coma for treatment of refractory status epilepticus |
| Q88067714 | What's new in status epilepticus? |
| Q91216003 | Why do patients die after status epilepticus? |
| Q103025647 | Would people living with epilepsy benefit from palliative care? |
| Q53470121 | [Can treatment with anesthetic anticonvulsive drugs worsen outcome in status epilepticus?] |
Search more.